TrialFrontiers of medicine2023

Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapy.

Zixun Yan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.